(NEW YORK) -- Pfizer is advancing Phase 2/3 clinical trials for young kids at lower doses than vaccines for adults, the pharmaceutical company announced Tuesday. Based on safety, efficacy and tolerability data from Pfizer's Phase 1 trial, the company will use 10 micrograms of each... Read More.
(NEW YORK) -- COVID-19 vaccine eligibility has now been widened for children ages 12 and up. The U.S. Food and Drug Administration (FDA) on Monday authorized the Pfizer vaccine for children ages 12 to 15, bolstering chances for a safe return to full-time school in... Read More.
(NEW YORK) -- The Pfizer vaccine has been authorized for children ages 12 and up, widening the U.S. population that will be protected against the virus and bolstering chances for a safe return to full-time school in the fall, the Food and Drug Administration... Read More.
(NEW YORK) -- Pfizer and partner BioNtech announced they are starting the process to seek full Food and Drug Administration approval in the U.S. for their COVID-19 vaccine. Since December, their vaccine has been distributed in the U.S. under an "emergency use authorization," which is... Read More.
(NEW YORK) -- Pfizer and BioNTech will be providing COVID-19 vaccines to Olympic athletes participating in the summer games in Tokyo. The pharmaceutical companies signed a memorandum of understanding with the International Olympic Committee on Thursday to donate doses of the vaccine to athletes and... Read More.
(WASHINGTON) -- Counterfeit versions of Pfizer's COVID-19 vaccine have been identified in Mexico and Poland, a Pfizer spokesperson confirmed to ABC News -- adding to the running tally of scam attempts in the U.S. and internationally. "We are cognizant that in this type of environment... Read More.
(NEW YORK) -- The first real-world study pitting COVID-19 variants against the Pfizer vaccine showed that the variant first detected in South Africa may be able to evade some vaccine protection, new research conducted in Israel found. While "breakthrough" COVID-19 cases, meaning people who get... Read More.
By Meredith Deliso and Sony Salzman, ABC News(NEW YORK) -- Pfizer and BioNTech's COVID-19 vaccine is 100% effective against the virus in children ages 12 to 15, the companies announced in a press release Wednesday.In a placebo-controlled trial... Read More.
By ERIN SCHUMAKER, ABC News (NEW YORK) -- The Pfizer and Moderna vaccines are safe and effective in pregnant and lactating women and those women are able to pass protective antibodies to their newborns, according to a new study.To come to... Read More.
By DR. TARUN JAIN and SONY SALZMAN, ABC News(NEW YORK) -- Pfizer now joins Moderna in testing its vaccine in younger children.The company will enroll 4,500 children in a trial that will ultimately include children as young as... Read More.
By Dr. ERIC SILBERMAN, MD, ABC News(NEW YORK) -- Pfizer's vaccine is successful in preventing not only symptomatic COVID-19, but also asymptomatic disease according to new real-world data, Israel's Ministry of Health and Pfizer/BioNTech announced Thursday.As concerning COVID... Read More.
By DR. STEPHANIE WIDMER, ABC News(NEW YORK) -- Pfizer and BioNTech have announced a new trial to evaluate their COVID-19 vaccine in pregnant women.Their vaccine, along with Moderna's, are the two mRNA vaccines currently available in the United... Read More.